Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancer

References

• International Agency for Research on CancerGLOBOCAN 2008: The GLOBOCAN Project [website on the Internet]LyonInternational Agency for Research on Cancer2010 Available from: http://globocan.iarc.fr/Accessed December 19, 2011
   Google Scholar
• SiegelRWardEBrawleyOJemalACancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deathsCA Cancer J Clin201161421223621685461
   PubMed Web of Science ®Google Scholar
• JemalABrayFCenterMMGlobal cancer statisticsCA Cancer J Clin2011612699021296855
   PubMed Web of Science ®Google Scholar
• ParkinDMThe role of cancer registries in cancer controlInt J Clin Oncol200813210211118463952
   PubMed Web of Science ®Google Scholar
• ParkinDMFerlayJCuradoMPFifty years of cancer incidence: CI5 I-IXInt J Cancer2010127122918292721351270
   PubMed Web of Science ®Google Scholar
• BrennanPHainautPBoffettaPGenetics of lung-cancer susceptibilityLancet Oncol201112439940820951091
   PubMed Web of Science ®Google Scholar
• ChristianiDCThe environment and the lung: detection, prevention, and mechanism of diseaseProc Am Thorac Soc20107214614820427589
   PubMedGoogle Scholar
• SugimuraHTaoHSuzukiMGenetic susceptibility to lung cancerFront Biosci (Schol Ed)201131463147721622282
   PubMedGoogle Scholar
• PetersSKromhoutHOlssonACOccupational exposure to organic dust increases lung cancer risk in the general populationThorax8192011 Epub ahead of print
   Web of Science ®Google Scholar
• SimSCIngelman-SundbergMThe Human Cytochrome P450 (CYP) Allele Nomenclature website: a peer-reviewed database of CYP variants and their associated effectsHum Genomics20104427828120511141
   PubMedGoogle Scholar
• SimSCAltmanRBIngelman-SundbergMDatabases in the area of pharmacogeneticsHum Mutat201132552653121309040
   PubMed Web of Science ®Google Scholar
• JohanssonIIngelman-SundbergMGenetic polymorphism and toxicology – with emphasis on cytochrome P450Toxicol Sci2011120111321149643
   PubMed Web of Science ®Google Scholar
• ZhongYCarmellaSGUpadhyayaPImmediate consequences of cigarette smoking: rapid formation of polycyclic aromatic hydrocarbon diol epoxidesChem Res Toxicol201124224625221184614
   PubMed Web of Science ®Google Scholar
• PrattMMJohnKMacleanABPolycyclic aromatic hydrocarbon (PAH) exposure and DNA adduct semi-quantitation in archived human tissuesInt J Environ Res Public Health2011872675269121845152
   PubMed Web of Science ®Google Scholar
• KimJSParkJYChungWYPolymorphisms in genes coding for enzymes metabolizing smoking-derived substances and the risk of periodontitisJ Clin Periodontol2004311195996415491310
   PubMed Web of Science ®Google Scholar
• SmithLEDenissenkoMFBennettWPTargeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbonsJ Natl Cancer Inst2000921080381110814675
   PubMed Web of Science ®Google Scholar
• MollerupSBergeGBaeraRSex differences in risk of lung cancer: Expression of genes in the PAH bioactivation pathway in relation to smoking and bulky DNA adductsInt J Cancer2006119474174416557573
   PubMed Web of Science ®Google Scholar
• GasperinoJGender is a risk factor for lung cancerMed Hypotheses201176332833121106301
   PubMed Web of Science ®Google Scholar
• UppstadHOsnesGHColeKJSex differences in susceptibility to PAHs is an intrinsic property of human lung adenocarcinoma cellsLung Cancer201171326427020951464
   PubMed Web of Science ®Google Scholar
• PiipariRSavelaKNurminenTExpression of CYP1A1, CYP1B1 and CYP3A, and polycyclic aromatic hydrocarbon-DNA adduct formation in bronchoalveolar macrophages of smokers and non-smokersInt J Cancer200086561061610797280
   PubMed Web of Science ®Google Scholar
• SmithTJGuoZGuengerichFPYangCSMetabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by human cytochrome P450 1A2 and its inhibition by phenethyl isothiocyanateCarcinogenesis19961748098138625495
   PubMed Web of Science ®Google Scholar
• BloomJHinrichsALWangJCThe contribution of common CYP2A6 alleles to variation in nicotine metabolism among European-AmericansPharmacogenet Genomics201121740341621597399
   PubMed Web of Science ®Google Scholar
• BartschHRojasMAlexandrovKMetabolic polymorphism affecting DNA binding and excretion of carcinogens in humansPharmacogenetics19955Spec NoS84S907581496
   PubMedGoogle Scholar
• BartschHNairURischAGenetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancersCancer Epidemiol Biomarkers Prev20009132810667460
   PubMed Web of Science ®Google Scholar
• ChenZLiZNiuXThe effect of CYP1A1 polymorphisms on the risk of lung cancer: a global meta-analysis based on 71 case-control studiesMutagenesis201126343744621402622
   PubMed Web of Science ®Google Scholar
• ZienolddinySSkaugVLandvikNEThe TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lungCarcinogenesis20093081368137119465454
   PubMed Web of Science ®Google Scholar
• XunWWBrennanPTjonnelandASingle-nucleotide polymorphisms (5p15.33, 15q25.1, 6p22.1, 6q27 and 7p15.3) and lung cancer survival in the European Prospective Investigation into Cancer and Nutrition (EPIC)Mutagenesis201126565766621750227
   PubMed Web of Science ®Google Scholar
• ChenBQiuLXLiYThe CYP1B1 Leu432Val polymorphism contributes to lung cancer risk: evidence from 6501subjectsLung Cancer201070324725220395011
   PubMed Web of Science ®Google Scholar
• HannaIHDawlingSRoodiNGuengerichFPParlFFCytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activityCancer Res200060133440344410910054
   PubMed Web of Science ®Google Scholar
• HelmigSSeelingerJUPhilipp-GehlhaarMDohrelJSchneiderJCyp1B1 mRNA expression in correlation to cotinine levels with respect to the Cyp1B1 L432V gene polymorphismEur J Epidemiol2010251286787320830506
   PubMed Web of Science ®Google Scholar
• HelmigSSeelingerJUDohrelJSchneiderJRNA expressions of AHR, ARNT and CYP1B1 are influenced by AHR Arg554 Lys polymorphismMol Genet Metab20111041–218018421742528
   PubMed Web of Science ®Google Scholar
• Laroche-ClaryALe MorvanVYamoriTRobertJCytochrome P450 1B1 gene polymorphisms as predictors of anticancer drug activity: studies with in vitro modelsMol Cancer Ther20109123315332120889730
   PubMed Web of Science ®Google Scholar
• AdaAOKunakCHancerFCYP and GST polymorphisms and survival in advanced non-small cell lung cancer patientsNeoplasma201057651252120845989
   PubMed Web of Science ®Google Scholar
• Brigelius-FloheRKippAGlutathione peroxidases in different stages of carcinogenesisBiochim Biophys Acta20091790111555156819289149
   PubMed Web of Science ®Google Scholar
• AgundezJAPolymorphisms of human N-acetyltransferases and cancer riskCurr Drug Metab20089652053118680472
   PubMed Web of Science ®Google Scholar
• ZienolddinySCampaDLindHA comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokersCarcinogenesis20082961164116918258609
   PubMed Web of Science ®Google Scholar
• McKayJDHashibeMHungRJSequence variants of NAT1 and NAT2 and other xenometabolic genes and risk of lung and aerodigestive tract cancers in Central EuropeCancer Epidemiol Biomarkers Prev200817114114718199719
   PubMed Web of Science ®Google Scholar
• BocciaSBoffettaPBrennanPMeta-analyses of the methyl-enetetrahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancerCancer Lett20092731556118789576
   PubMed Web of Science ®Google Scholar
• MaoRFanYJinYBaiJFuSMethylenetetrahydrofolate reductase gene polymorphisms and lung cancer: a meta-analysisJ Hum Genet200853434034818340404
   PubMed Web of Science ®Google Scholar
• TilakARKumarSJainMAssociation of functionally important polymorphism of microsomal epoxide hydrolase gene (EPHX1) with lung cancer susceptibilityCancer Invest201129641141821649467
   PubMed Web of Science ®Google Scholar
• LeeJDahlMNordestgaardBGGenetically lowered microsomal epoxide hydrolase activity and tobacco-related cancer in 47,000 individualsCancer Epidemiol Biomarkers Prev20112081673168221653646
   PubMed Web of Science ®Google Scholar
• KiyoharaCYoshimasuKTakayamaKNakanishiYEPHX1 polymorphisms and the risk of lung cancer: a HuGE reviewEpidemiology2006171899916357600
   PubMed Web of Science ®Google Scholar
• AtaianYKrebsJEFive repair pathways in one context: chromatin modification during DNA repairBiochem Cell Biol200684449050416936822
   PubMed Web of Science ®Google Scholar
• MannussATrappOPuchtaHGene regulation in response to DNA damageBiochim Biophys Acta8162011 Epub ahead of print
   Web of Science ®Google Scholar
• ShenHSpitzMRQiaoYSmoking, DNA repair capacity and risk of nonsmall cell lung cancerInt J Cancer20031071848812925960
   PubMed Web of Science ®Google Scholar
• RouillonCWhiteMFThe evolution and mechanisms of nucleotide excision repair proteinsRes Microbiol20111621192620863882
   PubMed Web of Science ®Google Scholar
• KiyoharaCYoshimasuKGenetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysisInt J Med Sci200742597117299578
   PubMedGoogle Scholar
• KiyoharaCTakayamaKNakanishiYLung cancer risk and genetic polymorphisms in DNA repair pathways: a meta-analysisJ Nucleic Acids2010201070176020981350
   PubMedGoogle Scholar
• MladenovEIliakisGInduction and repair of DNA double strand breaks: the increasing spectrum of non-homologous end joining pathwaysMutat Res20117111–2617221329706
   PubMed Web of Science ®Google Scholar
• HiomKCoping with DNA double strand breaksDNA Repair (Amst)20109121256126321115283
   PubMed Web of Science ®Google Scholar
• KrystonTBGeorgievABPissisPGeorgakilasAGRole of oxidative stress and DNA damage in human carcinogenesisMutat Res20117111–219320121216256
   PubMed Web of Science ®Google Scholar
• RobertsonABKlunglandARognesTLeirosIDNA repair in mammalian cells: Base excision repair: the long and short of itCell Mol Life Sci200966698199319153658
   PubMed Web of Science ®Google Scholar
• KlunglandABjellandSOxidative damage to purines in DNA: role of mammalian Ogg1DNA Repair (Amst)20076448148817127104
   PubMed Web of Science ®Google Scholar
• SvilarDGoellnerEMAlmeidaKHSobolRWBase excision repair and lesion-dependent subpathways for repair of oxidative DNA damageAntioxid Redox Signal201114122491250720649466
   PubMed Web of Science ®Google Scholar
• VensCBeggACTargeting base excision repair as a sensitization strategy in radiotherapySemin Radiat Oncol201020424124920832016
   PubMed Web of Science ®Google Scholar
• ChristmannMVerbeekBRoosWPKainaBO(6)-Methylguanine-DNA methyltransferase (MGMT) in normal tissues and tumors: Enzyme activity, promoter methylation and immunohistochemistryBiochim Biophys Acta20111816217919021745538
   PubMed Web of Science ®Google Scholar
• JhaPSuriVJainAO6-methylguanine DNA methyltransferase gene promoter methylation status in gliomas and its correlation with other molecular alterations: first Indian report with review of challenges for use in customized treatmentNeurosurgery20106761681169121107199
   PubMed Web of Science ®Google Scholar
• VineisPManuguerraMKavvouraFKA field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibilityJ Natl Cancer Inst20091011243619116388
   PubMedGoogle Scholar
• RicceriFMatulloGVineisPIs there evidence of involvement of DNA repair polymorphisms in human cancer?Mutat Res8122011 Epub ahead of print
   Web of Science ®Google Scholar
• OlaussenKADunantAFouretPDNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapyN Engl J Med20063551098399116957145
   PubMed Web of Science ®Google Scholar
• YuHZhaoHWangLEAn analysis of single nucleotide polymorphisms of 125 DNA repair genes in the Texas genome-wide association study of lung cancer with a replication for the XRCC4 SNPsDNA Repair (Amst)201110439840721296624
   PubMed Web of Science ®Google Scholar
• ChristianiDCERCC2/XPD polymorphisms and lung cancer riskJ Thorac Oncol20116123323521178723
   PubMed Web of Science ®Google Scholar
• HungRJHallJBrennanPBoffettaPGenetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE reviewAm J Epidemiol20051621092594216221808
   PubMed Web of Science ®Google Scholar
• ZienolddinySCampaDLindHPolymorphisms of DNA repair genes and risk of non-small cell lung cancerCarcinogenesis200627356056716195237
   PubMed Web of Science ®Google Scholar
• ParkSYKimYMPyoHGefitinib radiosensitizes non-small cell lung cancer cells through inhibition of ataxia telangiectasia mutatedMol Cancer2010922220731837
   PubMed Web of Science ®Google Scholar
• LevineAJOrenMThe first 30 years of p53: growing ever more complexNat Rev Cancer200991074975819776744
   PubMed Web of Science ®Google Scholar
• BondGLHirshfieldKMKirchhoffTMDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent mannerCancer Res200666105104511016707433
   PubMed Web of Science ®Google Scholar
• MogiAKuwanoHTP53 mutations in nonsmall cell lung cancerJ Biomed Biotechnol2011201158392921331359
   PubMedGoogle Scholar
• BondGLHuWLevineAJMDM2 is a central node in the p53 pathway: 12 years and countingCurr Cancer Drug Targets2005513815720184
   PubMed Web of Science ®Google Scholar
• EyminBGazzeriSBrambillaCBrambillaEMdm2 overexpression and p14(ARF) inactivation are two mutually exclusive events in primary human lung tumorsOncogene200221172750276111965548
   PubMed Web of Science ®Google Scholar
• BondGLLevineAJA single nucleotide polymorphism in the p53 pathway interacts with gender, environmental stresses and tumor genetics to influence cancer in humansOncogene20072691317132317322917
   PubMed Web of Science ®Google Scholar
• BondGLHuWBondEEA single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humansCell2004119559160215550242
   PubMed Web of Science ®Google Scholar
• LindHEkstromPORybergDFrequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancerCancer Epidemiol Biomarkers Prev200716102077208117932356
   PubMed Web of Science ®Google Scholar
• SiddiqueMSabapathyKTrp53-dependent DNA-repair is affected by the codon 72 polymorphismOncogene200625253489350016462765
   PubMed Web of Science ®Google Scholar
• LindHZienolddinySEkstromPOSkaugVHaugenAAssociation of a functional polymorphism in the promoter of the MDM2 gene with risk of nonsmall cell lung cancerInt J Cancer2006119371872116496380
   PubMed Web of Science ®Google Scholar
• HuZMaHLuDGenetic variants in the MDM2 promoter and lung cancer risk in a Chinese populationInt J Cancer200611851275127816152608
   PubMed Web of Science ®Google Scholar
• PineSRMechanicLEBowmanEDMDM2 SNP309 and SNP354 are not associated with lung cancer riskCancer Epidemiol Biomarkers Prev20061581559156116896050
   PubMed Web of Science ®Google Scholar
• WilkeningSBermejoJLHemminkiKMDM2 SNP309 and cancer risk: a combined analysisCarcinogenesis200728112262226717827408
   PubMed Web of Science ®Google Scholar
• WoXHanDSunHMDM2 SNP309 contributes to tumor susceptibility: A meta-analysisJ Genet Genomics201138834135021867960
   PubMed Web of Science ®Google Scholar
• GrocholaLFZeron-MedinaJMeriauxSBondGLSingle-nucleotide polymorphisms in the p53 signaling pathwayCold Spring Harb Perspect Biol201025a00103220452958
   PubMed Web of Science ®Google Scholar
• DongJRenBHuZMDM2 SNP309 contributes to non-small cell lung cancer survival in ChineseMol Carcinog201150643343821268124
   PubMed Web of Science ®Google Scholar
• VikhanskayaFSiddiqueMMKeiLMBrogginiMSabapathyKEvaluation of the combined effect of p53 codon 72 polymorphism and hotspot mutations in response to anticancer drugsClin Cancer Res200511124348435615958617
   PubMed Web of Science ®Google Scholar
• SonJWKangHKChaeMHPolymorphisms in the caspase-8 gene and the risk of lung cancerCancer Genet Cytogenet2006169212112716938569
   PubMedGoogle Scholar
• ZienolddinySMartinsenKSkuagVEkstromPOHaugenAThe caspase-8 insertion/deletion polymorphism and risk of non-small cell lung cancerAm J Biomed Sci20102121128
   Google Scholar
• BalkwillFCoussensLMCancer: an inflammatory linkNature2004431700740540615385993
   PubMed Web of Science ®Google Scholar
• CoussensLMWerbZInflammation and cancerNature2002420691786086712490959
   PubMed Web of Science ®Google Scholar
• BrennerDRMcLaughlinJRHungRJPrevious lung diseases and lung cancer risk: a systematic review and meta-analysisPLoS One201163e1747921483846
   PubMed Web of Science ®Google Scholar
• PineSRMechanicLEEnewoldLIncreased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancerJ Natl Cancer Inst2011103141112112221685357
   PubMedGoogle Scholar
• BiNYangMZhangLCyclooxygenase-2 genetic variants are associated with survival in unresectable locally advanced non-small cell lung cancerClin Cancer Res20101682383239020332326
   PubMed Web of Science ®Google Scholar
• WuYCSuLJWangHWCo-overexpression of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 adversely affects the postoperative survival in non-small cell lung cancerJ Thorac Oncol2010581167117420592629
   PubMed Web of Science ®Google Scholar
• KimSJRabbaniZNDongFPhosphorylated epidermal growth factor receptor and cyclooxygenase-2 expression in localized non-small cell lung cancerMed Oncol2010271919719235531
   PubMed Web of Science ®Google Scholar
• LiFLiuYChenHEGFR and COX-2 protein expression in non-small cell lung cancer and the correlation with clinical featuresJ Exp Clin Cancer Res2011302721385353
   PubMed Web of Science ®Google Scholar
• ElrodHAYuePKhuriFRSunSYCelecoxib antagonizes perifosine’s anticancer activity involving a cyclooxygenase-2-dependent mechanismMol Cancer Ther2009892575258519755515
   PubMed Web of Science ®Google Scholar
• FontaineEMcShaneJPageRAspirin and non-small cell lung cancer resections: effect on long-term survivalEur J Cardiothorac Surg2010381212620359903
   PubMed Web of Science ®Google Scholar
• PalSKFiglinRAReckampKTargeted therapies for non-small cell lung cancer: an evolving landscapeMol Cancer Ther2010971931194420571071
   PubMed Web of Science ®Google Scholar
• JuRWuDGuoLInhibition of pro-inflammatory cytokines in tumour associated macrophages is a potential anti-cancer mechanism of carboxyamidotriazoleEur J Cancer7162011 Epub ahead of print
   Web of Science ®Google Scholar
• CampaDZienolddinySMagginiVAssociation of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancerCarcinogenesis200425222923514604894
   PubMed Web of Science ®Google Scholar
• EngelsEAWuXGuJSystematic evaluation of genetic variants in the inflammation pathway and risk of lung cancerCancer Res200767136520652717596594
   PubMed Web of Science ®Google Scholar
• LindHZienolddinySRybergDInterleukin 1 receptor antagonist gene polymorphism and risk of lung cancer: a possible interaction with polymorphisms in the interleukin 1 beta geneLung Cancer200550328529016126303
   PubMed Web of Science ®Google Scholar
• ZienolddinySRybergDMagginiVPolymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancerInt J Cancer2004109335335614961572
   PubMed Web of Science ®Google Scholar
• LandvikNEHartKSkaugVA specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancerCarcinogenesis20093071186119219461122
   PubMed Web of Science ®Google Scholar
• LindHHaugenAZienolddinySDifferential binding of proteins to the IL1B -31 T/C polymorphism in lung epithelial cellsCytokine2007381434817587593
   PubMed Web of Science ®Google Scholar
• HartKHaugenAZienolddinySAllele-specific induction of IL1B-31T/C promoter polymorphism by lung carcinogensMutat Res20086561–2141818656550
   PubMed Web of Science ®Google Scholar
• van den BorstBSourenNYGielenMAssociation between the IL6-174G/C SNP and maximally attained lung functionThorax201166217918020864574
   PubMed Web of Science ®Google Scholar
• HeJQForemanMGShumanskyKAssociations of IL6 polymorphisms with lung function decline and COPDThorax200964869870419359268
   PubMed Web of Science ®Google Scholar
• GaoLBPanXMJiaJIL-8 -251 A/T polymorphism is associated with decreased cancer risk among population-based studies: evidence from a meta-analysisEur J Cancer20104681333134320400292
   PubMed Web of Science ®Google Scholar
• HullJAckermanHIslesKUnusual haplotypic structure of IL8, a susceptibility locus for a common respiratory virusAm J Hum Genet200169241341911431705
   PubMed Web of Science ®Google Scholar
• MekinianATamouzaRPavySFunctional study of TNF-alpha promoter polymorphisms: literature review and meta-analysisEur Cytokine Netw20112228810221768061
   PubMed Web of Science ®Google Scholar
• WeiSNiuJZhaoHAssociation of a novel functional promoter variant (rs2075533 C > T) in the apoptosis gene TNFSF8 with risk of lung cancer – a finding from Texas lung cancer genome-wide association studyCarcinogenesis201132450751521292647
   PubMed Web of Science ®Google Scholar
• HartKLandvikNELindHA combination of functional polymorphisms in the CASP8, MMP1, IL10 and SEPS1 genes affects risk of non-small cell lung cancerLung Cancer201171212312920471133
   PubMed Web of Science ®Google Scholar
• VogelUChristensenJWallinHPolymorphisms in genes involved in the inflammatory response and interaction with NSAID use or smoking in relation to lung cancer risk in a prospective studyMutat Res20086391–28910018164040
   PubMed Web of Science ®Google Scholar
• HungRJMcKayJDGaborieauVA susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25Nature2008452718763363718385738
   PubMed Web of Science ®Google Scholar
• McKayJDHungRJGaborieauVLung cancer susceptibility locus at 5p15.33Nat Genet200840121404140618978790
   PubMed Web of Science ®Google Scholar
• TournierJMBirembautPNicotinic acetylcholine receptors and predisposition to lung cancerCurr Opin Oncol2011231838721045689
   PubMed Web of Science ®Google Scholar
• SarginsonJEKillenJDLazzeroniLCMarkers in the 15q24 nicotinic receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapyAm J Med Genet B Neuropsychiatr Genet2011156B327528421268243
   PubMed Web of Science ®Google Scholar
• Kaur-KnudsenDBojesenSETybjaerg-HansenANordestgaardBGNicotinic acetylcholine receptor polymorphism, smoking behavior, and tobacco-related cancer and lung and cardiovascular diseases: a cohort studyJ Clin Oncol201129212875288221646606
   PubMed Web of Science ®Google Scholar
• YamamotoKOkamotoAIsonishiSOchiaiKOhtakeYA novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosisBiochem Biophys Res Commun200128041148115411162647
   PubMed Web of Science ®Google Scholar
• SenoglesSED2 s dopamine receptor mediates phospholipase D and antiproliferationMol Cell Endocrinol20032091–2616914604817
   PubMed Web of Science ®Google Scholar
• SenoglesSED2 dopamine receptor-mediated antiproliferation in a small cell lung cancer cell line, NCI-H69Anticancer Drugs200718780180717581302
   PubMed Web of Science ®Google Scholar
• CampaDZienolddinySLindHPolymorphisms of dopamine receptor/transporter genes and risk of non-small cell lung cancerLung Cancer2007561172317175058
   PubMed Web of Science ®Google Scholar
• HowladerNRiesLAMariottoABImproved estimates of cancer-specific survival rates from population-based dataJ Natl Cancer Inst2010102201584159820937991
   PubMedGoogle Scholar
• BrooksDRKlintADickmanPWStahleELambeMTemporal trends in non-small cell lung cancer survival in SwedenBr J Cancer200796351952217245337
   PubMed Web of Science ®Google Scholar
• BerrinoFDe AngelisRSantMSurvival for eight major cancers and all cancers combined for European adults diagnosed in 1995–1999: results of the EUROCARE-4 studyLancet Oncol20078977378317714991
   PubMed Web of Science ®Google Scholar
• StormHHEngholmGHakulinenTSurvival of patients diagnosed with cancer in the Nordic countries up to 1999–2003 followed to the end of 2006. A critical overview of the resultsActa Oncol201049553254420491522
   PubMed Web of Science ®Google Scholar
• AgarwalMBrahmandayGChmielewskiGWWelshRJRavikrishnanKPAge, tumor size, type of surgery, and gender predict survival in early stage (stage I and II) non-small cell lung cancer after surgical resectionLung Cancer201068339840219762109
   PubMed Web of Science ®Google Scholar
• ChanskyKSculierJPCrowleyJJThe International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancerJ Thorac Oncol20094779280119458556
   PubMed Web of Science ®Google Scholar
• Leon-AtancePMoreno-MataNGonzalez-AragonesesFMulticenter analysis of survival and prognostic factors in pathologic stage I non-small-cell lung cancer according to the new 2009 TNM classificationArch Bronconeumol201147944144621676516
   PubMed Web of Science ®Google Scholar
• Serrano-OlveraAGersonRAge associated survival rate in non small cell lung cancerGac Med Mex200914512735 Spanish19256408
   PubMed Web of Science ®Google Scholar
• VeenEJJanssen-HeijnenMLRitchieEDPneumonectomy for bronchogenic carcinoma: analysis of factors predicting short- and long-term outcomeInteract Cardiovasc Thorac Surg20099226026419443491
   PubMedGoogle Scholar
• PalmaDATyldesleySSheehanFStage I non-small cell lung cancer (NSCLC) in patients aged 75 years and older: does age determine survival after radical treatment?J Thorac Oncol20105681882420521349
   PubMed Web of Science ®Google Scholar
• SigelKBonomiMPackerSWisniveskyJEffect of age on survival of clinical stage I non-small-cell lung cancerAnn Surg Oncol20091671912191719408051
   PubMed Web of Science ®Google Scholar
• VisbalALWilliamsBANicholsFCIIIGender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002Ann Thorac Surg200478120921515223430
   PubMed Web of Science ®Google Scholar
• RingerGSmithJMEngelAMHendyMPLangJInfluence of sex on lung cancer histology, stage, and survival in a midwestern United States tumor registryClin Lung Cancer20057318018216354312
   PubMed Web of Science ®Google Scholar
• MooreRDohertyDChamberlainRKhuriFSex differences in survival in non-small cell lung cancer patients1974–1998Acta Oncol2004431576415068321
   PubMed Web of Science ®Google Scholar
• JubelirerSJVarelaNLWelchCAEmmettMKDoes sex make a difference in survival of patients undergoing resection for early stage non-small cell lung cancer (NSCLC)?W V Med J200910541822
   Google Scholar
• NealDEPSA testing for prostate cancer improves survival – but can we do better?Lancet Oncol201011870270320598635
   PubMed Web of Science ®Google Scholar
• HorganAMYangBAzadAKPharmacogenetic and germline prognostic markers of lung cancerJ Thorac Oncol20116229630421206385
   PubMed Web of Science ®Google Scholar
• AdaAOSuzenSHIscanMPolymorphisms of cytochrome P450 1A1, glutathione S-transferases M1 and T1 in a Turkish populationToxicol Lett2004151131131515177667
   PubMed Web of Science ®Google Scholar
• GotoIYonedaSYamamotoMKawajiriKPrognostic significance of germ line polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small cell lung cancerCancer Res19965616372537308706015
   PubMed Web of Science ®Google Scholar
• JinYXuHZhangCCombined effects of cigarette smoking, gene polymorphisms and methylations of tumor suppressor genes on non small cell lung cancer: a hospital-based case-control study in ChinaBMC Cancer20101042220704749
   PubMed Web of Science ®Google Scholar
• NieQYangXNAnSJCYP1A1*2A polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI and its combined effects with EGFR intron 1 (CA) n polymorphismEur J Cancer201147131962197021616658
   PubMed Web of Science ®Google Scholar
• PanJHHanJXWuJMShengLJHuangHNCYP450 polymorphisms predict clinic outcomes to vinorelbine-based chemotherapy in patients with non-small-cell lung cancerActa Oncol200746336136617450472
   PubMed Web of Science ®Google Scholar
• WeiSZZhanPShiMQPredictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysisMed Oncol201128131532120143185
   PubMed Web of Science ®Google Scholar
• RenSZhouSWuFAssociation between polymorphisms of DNA repair genes and survival of advanced NSCLC patients treated with platinum-based chemotherapyLung Cancer6132011 Epub ahead of print
   Web of Science ®Google Scholar
• ParkSYHongYCKimJHEffect of ERCC1 polymorphisms and the modification by smoking on the survival of non-small cell lung cancer patientsMed Oncol200623448949817303907
   PubMed Web of Science ®Google Scholar
• OkudaKSasakiHHikosakaYExcision repair cross complementation group 1 polymorphisms predict overall survival after platinum-based chemotherapy for completely resected non-small-cell lung cancerJ Surg Res2011168220621220070981
   PubMed Web of Science ®Google Scholar
• TakenakaTYanoTKiyoharaCEffects of excision repair cross-complementation group 1 (ERCC1) single nucleotide polymorphisms on the prognosis of non-small cell lung cancer patientsLung Cancer201067110110719361884
   PubMed Web of Science ®Google Scholar
• Quintela-FandinoMHittRMedinaPPDNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapyJ Clin Oncol200624264333433916896002
   PubMed Web of Science ®Google Scholar
• KalikakiAKanakiMVassalouHDNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancerClin Lung Cancer200910211812319362955
   PubMed Web of Science ®Google Scholar
• YuDKZhangXMLiuJCharacterization of functional excision repair cross-complementation group 1 variants and their association with lung cancer risk and prognosisClin Cancer Res20081492878288618451256
   PubMed Web of Science ®Google Scholar
• HanJYYoonKAParkJHDNA repair gene polymorphisms and benefit from gefitinib in never-smokers with lung adenocarcinomaCancer2011117143201320821264830
   PubMed Web of Science ®Google Scholar
• NogueiraACatarinoRCoelhoAInfluence of DNA repair RAD51 gene variants in overall survival of non-small cell lung cancer patients treated with first line chemotherapyCancer Chemother Pharmacol201066350150619960343
   PubMed Web of Science ®Google Scholar
• JaremkoMJustenhovenCSchrothWPolymorphism of the DNA repair enzyme XRCC1 is associated with treatment prediction in anthracycline and cyclophosphamide/methotrexate/5-fluorouracil-based chemotherapy of patients with primary invasive breast cancerPharmacogenet Genomics200717752953817558308
   PubMed Web of Science ®Google Scholar
• AhrendtSAHuYButaMp53 mutations and survival in stage I non-small-cell lung cancer: results of a prospective studyJ Natl Cancer Inst2003951396197012837832
   PubMedGoogle Scholar
• BoldriniLGisfrediSUrsinoSPrognostic impact of p53 Pro72 homozygous genotype in non-small cell lung cancer patientsOncol Rep200819377177318288414
   PubMed Web of Science ®Google Scholar
• ChienWCWongRHChengYWChenCYLeeHAssociations of MDM2 SNP309, transcriptional activity, mRNA expression, and survival in stage I non-small-cell lung cancer patients with wild-type p53 tumorsAnn Surg Oncol20101741194120219941079
   PubMed Web of Science ®Google Scholar
• ChuaHWNgDChooSEffect of MDM2 SNP309 and p53 codon 72 polymorphisms on lung cancer risk and survival among non-smoking Chinese women in SingaporeBMC Cancer2010108820219101
   PubMed Web of Science ®Google Scholar
• LiuLWuCWangYCombined effect of genetic polymorphisms in P53, P73, and MDM2 on non-small cell lung cancer survivalJ Thorac Oncol20116111793180021841506
   PubMed Web of Science ®Google Scholar
• ShihCMLinPTWangHCHuangWCWangYCLack of evidence of association of p21(WAF1/CIP1) polymorphism with lung cancer susceptibility and prognosis in TaiwanJpn J Cancer Res200091191510744039
   PubMedGoogle Scholar
• AndjelkovicTBankovicJStojsicJCoalterations of p53 and PTEN tumor suppressor genes in non-small cell lung carcinoma patientsTransl Res20111571192821146147
   PubMed Web of Science ®Google Scholar
• LandiLCappuzzoFTargeted therapies: Front-line therapy in lung cancer with mutations in EGFRNat Rev Clin Oncol201181057157321878894
   PubMed Web of Science ®Google Scholar
• DongJDaiJCShuYQPolymorphisms in EGFR and VEGF contribute to non-small-cell lung cancer survival in a Chinese populationCarcinogenesis20103161080108620400478
   PubMed Web of Science ®Google Scholar
• SasakiHOkudaKTakadaMA novel EGFR mutation D1012H and polymorphism at exon 25 in Japanese lung cancerJ Cancer Res Clin Oncol2008134121371137618478265
   PubMed Web of Science ®Google Scholar
• GiovannettiEZucaliPAPetersGJAssociation of polymorphisms in AKT1 and EGFR with clinical outcome and toxicity in non-small cell lung cancer patients treated with gefitinibMol Cancer Ther20109358159320159991
   PubMed Web of Science ®Google Scholar
• LiuGGurubhagavatulaSZhouWEpidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinibPharmacogenomics J20088212913817375033
   PubMed Web of Science ®Google Scholar
• MinamiyaYMiuraMHinaiYThe CRP 1846T/T genotype is associated with a poor prognosis in patients with non-small cell lung cancerTumour Biol201031667367920686879
   PubMedGoogle Scholar
• PankratzVSSunZAakreJSystematic evaluation of genetic variants in three biological pathways on patient survival in low-stage non-small cell lung cancerJ Thorac Oncol2011691488149521792076
   PubMed Web of Science ®Google Scholar
• PineSRMechanicLEAmbsSLung cancer survival and functional polymorphisms in MBL2, an innate-immunity geneJ Natl Cancer Inst200799181401140917848669
   PubMedGoogle Scholar
• HildebrandtMAKomakiRLiaoZGenetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancerPLoS One201058e1240220811626
   PubMed Web of Science ®Google Scholar
• SchetterAJHeegaardNHHarrisCCInflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathwaysCarcinogenesis2010311374919955394
   PubMed Web of Science ®Google Scholar
• VinciSGelminiSPratesiNGenetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancersClin Chem Lab Med992011 Epub ahead of print
   Web of Science ®Google Scholar
• NavarroADiazTGallardoEPrognostic implications of miR-16 expression levels in resected non-small-cell lung cancerJ Surg Oncol2010103541141521400525
   PubMed Web of Science ®Google Scholar
• SaitoMSchetterAJMollerupSThe association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma: a retrospective analysis of three cohortsClin Cancer Res20111771875188221350005
   PubMed Web of Science ®Google Scholar
• HeegaardNHSchetterAJWelshJACirculating microRNA expression profiles in early stage non-small cell lung cancerInt J Cancer542011 Epub ahead of print
   Web of Science ®Google Scholar
• ValachisAMauriDNeophytouCTranslational medicine and reliability of single-nucleotide polymorphism studies: can we believe in SNP reports or not?Int J Med Sci20118649250021897762
   PubMed Web of Science ®Google Scholar
• StewartDJTumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancerCrit Rev Oncol Hematol201053173234
   Web of Science ®Google Scholar
• RischAPlassCLung cancer epigenetics and geneticsInt J Cancer200812311718425819
   PubMed Web of Science ®Google Scholar
• HeYHoskinsJMMcleodHLCopy number variants in pharmacogenetic genesTrends Mol Med201117524425121388883
   PubMed Web of Science ®Google Scholar
• YangPLiYJiangRA rigorous and comprehensive validation: common genetic variations and lung cancerCancer Epidemiol Biomarkers Prev201019124024420056643
   PubMed Web of Science ®Google Scholar
• HuangYTHeistRSChirieacLRGenome-wide analysis of survival in early-stage non-small-cell lung cancerJ Clin Oncol200927162660266719414679
   PubMed Web of Science ®Google Scholar
• RussellPAWainerZWrightGMDoes lung adenocarcinoma subtype predict patient survival? A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma ClassificationJ Thorac Oncol2011691496150421642859
   PubMed Web of Science ®Google Scholar